Recap: BTK Inhibition and Treatment Options in Chronic Lymphocytic Leukemia
Experts discuss findings presented at ASH 2022 regarding chronic lymphocytic leukemia, and how they can be applied to clinical practice.
Recap: Alabama and Washington Universities Face-Off on Multiple Myeloma at ASH
Ravi Vij, MD, MBA, and Luciano Costa, MD, face off over myeloma data from ASH 2022.
Recap: Moffitt and Mayo Face-Off in CML Treatment Updates From ASH
A panel of experts from Moffitt and Mayo discuss newly published data from the 2022 American Society of Hematology (ASH) Annual Meeting and Exposition.
Recap: Teclistamab in Multiple Myeloma: A Patient’s Journey
Anne-Marie Jacob, a patient with multiple myeloma, discusses the treatment of multiple myeloma with bispecifics alongside a panel of experts.
Recap: Treatment Paradigms in Metastatic Breast Cancer: Real-world Patient Cases
Experts review the most recent data and discuss current strategies for the management of HR+ metastatic breast cancer.
Recap: Selinexor as a Treatment Option in Relapsed/Refractory Multiple Myeloma
Joshua Richter, MD, discusses the optimal use of selinexor in the treatment of relapsed/refractory multiple myeloma.
Recap: MRD Negativity, Frailty, and Emerging Therapies in Multiple Myeloma
An expert panel highlights novel therapeutic approaches for newly diagnosed and relapsed multiple myeloma.
